TY - JOUR T1 - Comparing Waves of COVID-19 in the US: Scale of response changes over time JF - medRxiv DO - 10.1101/2022.03.01.22271713 SP - 2022.03.01.22271713 AU - Robert L. Richards AU - Grant Foster AU - Bret D. Elderd AU - Tad A. Dallas Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/03/02/2022.03.01.22271713.abstract N2 - Local response to the SARS-CoV-2 pandemic differed spatially across the United States but the drivers of this spatial variation remain unclear. We approach this open question by studying the relationship between the growth rate of subsequent waves of the pandemic at the county level during the first year of the pandemic, asking whether state or county demographics better explain variation in this relationship. We found clear spatiotemporal patterns in the relationship between the slopes of subsequent waves in a given county. Generally the standardized difference between the growth rates of waves 1 and 2 and waves 2 and 3 were strongly positively correlated over short distances and shifted to a weak negative correlation at intermediate distances. We also found that peer county health group (a categorization of counties by demographic information relevant to public health) explained variation in response better between wave 1 and 2, while state identity was most important between wave 2 and 3. Taken together, we suggest that there are identifiable spatial patterns in pandemic response across the US but that the nature of these patterns change over the course of the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been supported by the U.S. National Science Foundation RAPID grant (NSF-DEB-2031196). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves openly available human data which can be obtained from the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (https://github.com/CSSEGISandData/COVID-19), CDC Nationwide Blood Donor Seroprevalence Survey (https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence), the County Health Status Indicator Peer Counties Tool (https://www.countyhealthrankings.org/resources/peer-counties-tool), and the US Census Bureau (https://www.census.gov/data/tables/time-series/demo/popest/2010s-counties-detail.html)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code to reproduce these analyses are available at https://doi.org/10.6084/m9.figshare.19285379. https://doi.org/10.6084/m9.figshare.19285379 ER -